A Multi-Scale Finite Element Method for Investigating Fiber Remodeling in Hypertrophic Cardiomyopathy

Arxiv
|September 29, 2025
PubMed

Insights

Hypertrophic cardiomyopathy (HCM) causes significant fiber disarray due to cellular abnormalities, disrupting heart mechanics. This study quantifies how different abnormalities impact disarray and cardiac function.

Area of Science:

  • Cardiovascular Research
  • Biomedical Engineering
  • Computational Biology

Background:

  • Hypertrophic cardiomyopathy (HCM) is characterized by myocardial fiber disarray, a key factor in cardiac dysfunction and heart failure.
  • Understanding the link between cellular abnormalities and fiber disarray is crucial for elucidating HCM pathophysiology.

Purpose of the Study:

  • To investigate how heterogeneous cellular abnormalities (hypercontractility, hypocontractility, fibrosis) contribute to fiber disarray in HCM.
  • To quantify the impact of these abnormalities on cardiac pumping function using a multiscale finite element model.

Main Methods:

  • Utilized the MyoFE multiscale finite element cardiac modeling framework.
  • Employed a stress-based law to simulate myofiber and collagen reorientation.
  • Quantified fiber disarray and assessed cardiac performance in models with heterogeneous cellular perturbations.

Main Results:

  • Heterogeneous cellular abnormalities significantly disrupt myocardial mechanics, leading to substantial fiber disarray.
  • The pattern and severity of fiber disarray varied based on the specific cellular perturbation (hypercontractility, hypocontractility, fibrosis).
  • Higher fiber disarray was consistently observed near the epicardium compared to the endocardium across all perturbed left ventricle (LV) models.

Conclusions:

  • HCM-induced cellular abnormalities are major drivers of myocardial fiber disarray, impacting cardiac function.
  • Regional differences in fiber disarray (epicardial vs. endocardial) are linked to myocardial mechanics and consistent with experimental findings.
  • Cardiac performance decline is exacerbated by fibrosis and hypocontractility, suggesting therapeutic targets for HCM remodeling.